Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Recent patents disclose novel ophthalmic drugs

Feb. 28, 2006

DuoTrav eye drops recommended for approval in Europe

Feb. 27, 2006

Three-year follow-up shows Retisert improves visual acuity

Feb. 23, 2006

Positive preliminary phase IIb results for ecabet sodium in dry eye syndrome

Feb. 23, 2006

Santen updates status of ophthalmic programs

Feb. 16, 2006

Novartis Ophthalmics to copromote Retisert with Bausch & Lomb

Feb. 14, 2006

New data presented on PEDF gene therapy for age-related macular degeneration / News in Context

Feb. 13, 2006

High intake of antioxidants may reduce the risk of AMD

Feb. 7, 2006

Acuity studies Cand5 for wet AMD and diabetic macular edema

Feb. 7, 2006

Macugen approved in Europe for wet AMD

Feb. 6, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 27, 2026.
Detecting the invisible: minimal residual disease at AACR 2026
BioWorld Science
Minimal residual disease (MRD) has become a central concept in modern oncology, reshaping how clinicians evaluate response, relapse risk and treatment precision....
A free gene therapy? Regeneron’s Otarmeni approved for hearing loss
BioWorld
Children and adults with a type of congenital hearing loss now have a free treatment option, with the U.S. FDA’s accelerated approval of Regeneron Pharmaceuticals...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Sichuan Kelun Pharmaceutical Research Institute discovers GPR6 inverse agonists
BioWorld Science
Sichuan Kelun Pharmaceutical Research Institute Co. Ltd. has identified G protein-coupled receptor 6 (GPR6) inverse agonists reported to be useful for the...